Phase II Trial of M7824 in Subjects With HPV Associated Malignancies
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Feb 2018
At a glance
- Drugs MSB 0011359C (Primary)
- Indications Anal cancer; Cervical cancer; Human papillomavirus infections; Neuroendocrine carcinoma; Oropharyngeal cancer; Penile cancer; Rectal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 13 Feb 2018 Planned initiation date changed from 15 Feb 2018 to 19 Feb 2018.
- 12 Feb 2018 New trial record
- 09 Feb 2018 Planned initiation date changed from 14 Feb 2018 to 15 Feb 2018.